Get 20% lifetime commission for referring investors to digrin.com
here.
Greenwich LifeSciences, Inc. (GLSI) Financials
GLSI Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 8.9 million | 5.8 million |
| March 31, 2026 | 10.5 million | 5.2 million |
| Dec. 31, 2025 | 6.2 million | 5.8 million |
| Sept. 30, 2025 | 3.8 million | 1.6 million |
GLSI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -1.9 million | 1.5 million |
| March 31, 2026 | -4.7 million | 1.5 million |
| Dec. 31, 2025 | -3.2 million | 2.2 million |
| Sept. 30, 2025 | -2.7 million | 1.5 million |
GLSI Net Income
No data available :(
GLSI Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 8.9 million | - | - |
| March 31, 2026 | 10.5 million | - | - |
| Dec. 31, 2025 | 6.2 million | - | - |
| Sept. 30, 2025 | 3.8 million | - | - |
GLSI Shares Outstanding
GLSI Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 3.6 million | 462931 | - |
| March 31, 2026 | 3 | 5.2 million | 518190 | - |
| Dec. 31, 2025 | 3 | 3.5 million | 653066 | - |
| Sept. 30, 2025 | 7 | 3.5 million | 653066 | - |
GLSI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | 3558 | 1779 |
| Dec. 31, 2025 | - | - |
| Sept. 30, 2025 | - | - |
GLSI
Price: $17.29
52 week price:
Earnings Per Share: -1.59 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 30476
Market Capitalization: 246.6 million